Mediatech and GlobalStem will collaborate on the development, manufacture, validation, and distribution of new products.

Mediatech and GlobalStem formed a strategic alliance to develop, manufacture, validate, and distribute embryonic stem cell-qualified growth media and supplements.

The goal of this alliance is to fill the need among stem cell researchers for fully characterized stem cell lines, validated feeder cells, qualified reagents, and characterization tools.

Mediatech reports that it has over 20 years of cGMP experience in the manufacture of sterile solutions, while GlobalStem will bring its experience in the research of embryonic stem cells to the relationship.

Previous articleSenetek Gains RNAi Technology for Treating Brain Tumors
Next articleXoma Completes $15-M NIAID Contract